ResearcherEhime UniversityActive in the last 2 years
Taira Kuroda
Matched on ORCID iD 0009-0002-1397-1714; OpenAlex author ID A5109663973. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 7
- A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with firs… Co-author DOI 10.1007/s10147-025-02717-1↗
- Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagn… Co-author DOI 10.3390/cancers15030561↗
- Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. Co-author DOI 10.1097/md.0000000000027591↗
- ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.3748-19↗
- Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance. Co-author DOI 10.1016/j.mayocp.2018.12.034↗
- Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients. First author DOI 10.1186/s12876-017-0623-8↗
- Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinica… Co-author DOI 10.1186/1471-230x-13-134↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshinori Ohno · 7 shared papers, 2013–2025 · strength 0.70
- Paper A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable adva… DOI 10.1007/s10147-025-02717-1↗
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Mitsuhito Koizumi · 7 shared papers, 2013–2025 · strength 0.70
- Paper A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable adva… DOI 10.1007/s10147-025-02717-1↗
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Teru Kumagi · 7 shared papers, 2013–2025 · strength 0.70
- Paper A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable adva… DOI 10.1007/s10147-025-02717-1↗
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Yoichi Hiasa · 7 shared papers, 2013–2025 · strength 0.70
- Paper A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable adva… DOI 10.1007/s10147-025-02717-1↗
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Nobuaki Azemoto · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Yoshinori Tanaka · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Takashi Terao · 5 shared papers, 2017–2023 · strength 0.47
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Ichinosuke Hyodo · 2 shared papers, 2021–2025 · strength 0.31
- Akinori Asagi · 1 shared paper, 2025 · strength 0.20
- Toru Otsuru · 1 shared paper, 2025 · strength 0.20
- Kaori Hino · 1 shared paper, 2025 · strength 0.20
- Yuki Numata · 1 shared paper, 2025 · strength 0.20
- Hiroshi Ishii · 2 shared papers, 2019–2020 · strength 0.16
- Masanori Abe · 2 shared papers, 2013–2020 · strength 0.11
- Morikazu Onji · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.